Evidence map›Paper›PMID 41723393›Full record

ArticleBMC complementary medicine and therapies2026

Ophiopogon japonicus-derived plant exosomes: a promising strategy for blocking the progression of diabetic vasculopathy to myocardial infarction.

Yan Pan, Meiling Tan, Xiaoying Li, Qianni Chen, Jie Tao, Xiaojuan Lin, Zhicong Zeng, Yinzhi Song, Feng Jiang

Abstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yan Pan *Department of Diabetology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, The Seventh Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, 518100, China.
Meiling Tan *Wenhua Community Health Service Center, Shenzhen Luohu Hospital Group, Shenzhen, 518001, China.
Xiaoying LiDepartment of Cardiology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, The Seventh Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, 518100, China.
Qianni ChenDepartment of Cardiology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, The Seventh Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, 518100, China.
Jie TaoDepartment of Cardiology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, The Seventh Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, 518100, China.
Xiaojuan LinDepartment of Cardiovascular Disease, Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, China.
Zhicong ZengDepartment of Cardiology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, The Seventh Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, 518100, China. zzcong23@126.com.
Yinzhi SongDepartment of Cardiology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, The Seventh Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, 518100, China. IAMWOLF1009@outlook.com.
Feng JiangDepartment of Cardiology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, The Seventh Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, 518100, China. 691859552@qq.com.

Funding

National Natural Science Foundation of China 82374383
6 · The paper itself

Abstract

backgroundDiabetic vasculopathy(DV) marks the beginning of the progression from diabetes to myocardial infarction(MI). However, the core genes associated with this disease progression remain unclear, and effective intervention measures are also relatively scarce. This study aims to identify the core genes related to the progression of DV to MI and to evaluate the potential of Ophiopogon-japonicus-derived plant exosomes in blocking this process.

methodsCore targets closely associated with the progression of DV to MI were identified through a dual-disease transcriptome analysis from multidimensional aspects including immune infiltration, senescence, and PANoptosis. Subsequently, we isolated plant exosomes derived from Ophiopogon-japonicus(PEDOs) and characterized by electron microscopic imaging and NTA. Further, we evaluated the potential of PEDOs in ameliorating vascular endothelial cell dysfunction under hyperglycemic conditions through flow cytometry, telomerase activity assays, wound healing assays, tube formation assays, western blot, and fluorescence imaging analysis.

resultsOur findings demonstrated that LIMA1, IL1β, TNF-α, and DKK1 served as the core targets involved in the progression from DV to MI. PEDOs significantly inhibited the expression of these core genes under high-glucose conditions and suppressed the apoptosis of vascular endothelial cells. More importantly, PEDOs significantly promoted angiogenesis by relieving the inhibition of Wnt/β-Catenin signaling by DKK1, and regulated cholesterol metabolism by inhibiting LIMA1 to reduce the uptake of Ox-LDL. However, PEDOs exhibited no significant effect on telomerase activity.

conclusionLIMA1, IL1β, TNF-α, and DKK1 serve as the core targets involved in the progression from DV to MI. PEDOs significantly improve the functional status of vascular endothelial cells under hyperglycemic conditions, representing a promising strategy to prevent the progression of DV to MI.

Indexed as

Diabetic AngiopathiesExosomesMyocardial InfarctionOphiopogonPlant ExtractsDisease ProgressionHumansPlant ExtractsDiabetic vasculopathyDual-disease dynamic transcriptomics analysisMyocardial infarctionOphiopogon japonicusPlant exosome

Identifiers

PMID41723393
PMCPMC13032630

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.